# A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor

> **NCT04937920** · PHASE2 · COMPLETED · sponsor: **DermBiont, Inc.** · enrollment: 34 (actual)

## Conditions studied

- Tinea Versicolor

## Interventions

- **BIOLOGICAL:** DBI-002 probiotic gel
- **BIOLOGICAL:** Aqueous gel

## Key facts

- **NCT ID:** NCT04937920
- **Lead sponsor:** DermBiont, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-16
- **Primary completion:** 2021-09-20
- **Final completion:** 2021-11-04
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04937920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04937920, "A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04937920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*